Claire Curtis

902 total citations
9 papers, 475 citations indexed

About

Claire Curtis is a scholar working on Rheumatology, Hematology and Genetics. According to data from OpenAlex, Claire Curtis has authored 9 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Rheumatology, 5 papers in Hematology and 4 papers in Genetics. Recurrent topics in Claire Curtis's work include Chronic Myeloid Leukemia Treatments (5 papers), Eosinophilic Disorders and Syndromes (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Claire Curtis is often cited by papers focused on Chronic Myeloid Leukemia Treatments (5 papers), Eosinophilic Disorders and Syndromes (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Claire Curtis collaborates with scholars based in United Kingdom, Germany and Italy. Claire Curtis's co-authors include Nicholas C.P. Cross, Francis Grand, Katherine Waghorn, David J. Bunyan, Diana Eccles, Andreas Reiter, Julie Sillibourne, John F. Harvey, N. Simon Thomas and Peter J. Duncan and has published in prestigious journals such as Blood, British Journal of Cancer and British Journal of Haematology.

In The Last Decade

Claire Curtis

9 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claire Curtis United Kingdom 7 217 177 154 138 94 9 475
Shashikant Kulkarni United States 5 135 0.6× 95 0.5× 170 1.1× 126 0.9× 68 0.7× 8 453
Alina Dulau‐Florea United States 14 224 1.0× 293 1.7× 126 0.8× 161 1.2× 60 0.6× 29 624
Leonardo Boiocchi United States 16 127 0.6× 299 1.7× 163 1.1× 339 2.5× 23 0.2× 29 610
Janet L. Lukacs United States 12 89 0.4× 109 0.6× 386 2.5× 383 2.8× 145 1.5× 27 680
Ana C. Glembotsky Argentina 17 100 0.5× 311 1.8× 164 1.1× 552 4.0× 86 0.9× 31 731
Els Lierman Belgium 10 207 1.0× 156 0.9× 154 1.0× 191 1.4× 10 0.1× 19 453
Stéphanie Struski France 16 40 0.2× 134 0.8× 264 1.7× 171 1.2× 106 1.1× 30 596
C. I. Amos United States 6 123 0.6× 86 0.5× 90 0.6× 38 0.3× 84 0.9× 7 393
T Flores Spain 9 55 0.3× 112 0.6× 232 1.5× 124 0.9× 36 0.4× 21 570
Sverre Heim Sweden 14 82 0.4× 65 0.4× 278 1.8× 200 1.4× 143 1.5× 16 706

Countries citing papers authored by Claire Curtis

Since Specialization
Citations

This map shows the geographic impact of Claire Curtis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Curtis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Curtis more than expected).

Fields of papers citing papers by Claire Curtis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire Curtis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Curtis. The network helps show where Claire Curtis may publish in the future.

Co-authorship network of co-authors of Claire Curtis

This figure shows the co-authorship network connecting the top 25 collaborators of Claire Curtis. A scholar is included among the top collaborators of Claire Curtis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire Curtis. Claire Curtis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Curtis, Claire, et al.. (2018). NOACs Now Mainstream for the Use of Anticoagulation in Non-Valvular Atrial Fibrillation in Australia. Heart Lung and Circulation. 28(4). e40–e42. 13 indexed citations
2.
Curtis, Claire, Francis Grand, Pellegrino Musto, et al.. (2007). Two novel imatinib‐responsive PDGFRA fusion genes in chronic eosinophilic leukaemia. British Journal of Haematology. 138(1). 77–81. 55 indexed citations
3.
Walz, Christoph, Claire Curtis, Susanne Schnittger, et al.. (2006). Transient response to imatinib in a chronic eosinophilic leukemia associated with ins(9;4)(q33;q12q25) and a CDK5RAP2‐PDGFRA fusion gene. Genes Chromosomes and Cancer. 45(10). 950–956. 56 indexed citations
4.
Score, J, Claire Curtis, Katherine Waghorn, et al.. (2006). Identification of a novel imatinib responsive KIF5B-PDGFRA fusion gene following screening for PDGFRA overexpression in patients with hypereosinophilia. Leukemia. 20(5). 827–832. 79 indexed citations
5.
Curtis, Claire, Jane F. Apperley, Michael Jeng, et al.. (2005). The Platelet-Derived Growth Factor Receptor beta Fuses to Two Distinct Loci at 3p21 in Imatinib Responsive Chronic Eosinophilic Leukemia.. Blood. 106(11). 3253–3253. 7 indexed citations
6.
Jones, Amy V., Richard T. Silver, Katherine Waghorn, et al.. (2005). Minimal molecular response in polycythemia vera patients treated with imatinib or interferon alpha. Blood. 107(8). 3339–3341. 88 indexed citations
7.
Walz, Christoph, Beate Schultheis, Georgia Metzgeroth, et al.. (2005). Transient Response to Imatinib in an Atypical Chronic Myeloproliferative Disease Associated with ins(9;4)(q34;q21q31) and a CDK5RAP2-PDGFRA Fusion Gene.. Blood. 106(11). 3281–3281. 1 indexed citations
8.
Pigatto, Francesca, Adrian C Bateman, David J. Bunyan, et al.. (2004). Economic and Practical Factors in Diagnosing HNPCC Using Clinical Criteria, Immunohistochemistry and Microsatellite Instability Analysis. Hereditary Cancer in Clinical Practice. 2(4). 175–84. 6 indexed citations
9.
Bunyan, David J., Diana Eccles, Julie Sillibourne, et al.. (2004). Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification. British Journal of Cancer. 91(6). 1155–1159. 170 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shashikant Kulkarni Breakdown of academic impact, for papers by Alina Dulau‐Florea Breakdown of academic impact, for papers by Leonardo Boiocchi Breakdown of academic impact, for papers by Janet L. Lukacs Breakdown of academic impact, for papers by Ana C. Glembotsky Breakdown of academic impact, for papers by Els Lierman Breakdown of academic impact, for papers by Stéphanie Struski Breakdown of academic impact, for papers by C. I. Amos Breakdown of academic impact, for papers by T Flores Breakdown of academic impact, for papers by Sverre Heim
Rankless by CCL
2026